It led to an increase in nephrin expression, improvement of the endothelial dysfunction due to decreases in endothelin 1 (ET-1) and plasminogen activator inhibitor 1 (PAI-1), and an increase in endothelial nitric oxide synthase (eNOS) expression in the renal cortex [54]. The gene discussed is EDN1; the disease is endothelial dysfunction.